The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks for shoulder surgery.

Trial Profile

The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks for shoulder surgery.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2014

At a glance

  • Drugs Dexmedetomidine (Primary) ; Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Mar 2012 Planned End Date changed to 12 Oct 2013.
    • 22 Mar 2012 Planned initiation date changed from 12 Oct 2011 to NULL.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top